Prenatal Exposure Effects Psychophysiology Study
PEEPS
Prenatal Cocaine and Neurobehavioral Factors Underlying Mother-Infant Interaction
PEEPS
Prenatal Cocaine and Neurobehavioral Factors Underlying Mother-Infant Interaction
Sponsor study identifier
observational
150
1 country
1
Study Start
July 2008
Actual (reported)Primary Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The purpose of the study is to understand the biology and behavior of early mother-infant attachment, and to investigate how it may be affected by prenatal substance exposures. The investigators are interested in how drugs such as cocaine, alcohol, marijuana and cigarette smoking affect both mother and baby.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2008
Actual (reported)May 28, 2010
Actual (reported)June 2, 2010
Actual (reported)January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Determine the effect of prenatal cocaine exposure on the neonatal brain. ventricular volumes
2 to 4 weeks of age
Use of cocaine at anytime during pregnancy. Subjects may also have used other drugs in combination with Cocaine
Subjects may have used any of these drugs during pregnancy, alone or in combination. This group has not used cocaine during pregnancy.
Subjects did not use any of the following drugs during pregnancy: cocaine, nicotine, alcohol, marijuana.
Pregnant women or mothers with their newborn infants.
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Plasma from mothers and buccal cells from infants will be stored for possible DNA analysis of target genes pending additional funding.
Karen Grewen, PhD
University of North Carolina, Chapel Hill
First Submitted
May 28, 2010
First Posted
June 2, 2010
Study Start
July 2008
Actual (reported)Primary Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
Contact the study team to confirm eligibility.
Study Completion
January 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 4, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: